Related Experiment Videos
Toward a breast cancer vaccine: work in progress
Leisha A Emens1, Elizabeth M Jaffee
1Sidney Kimmel, Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA. emensle@jhmi.edu
Oncology (Williston Park, N.Y.)
|October 23, 2003
Summary
Breast cancer vaccines harness the immune system for targeted treatment with minimal toxicity. Immunotherapy offers durable effects and potential for breast cancer prevention, building on advances in biotechnology and immunology.
Area of Science:
- Oncology
- Immunology
- Biotechnology
Background:
- Traditional breast cancer treatments face challenges like drug resistance.
- Advances in immunology and biotechnology present new therapeutic avenues.
- Cancer vaccines offer a novel approach to harnessing the immune system.
Purpose of the Study:
- To explore the therapeutic advantages of cancer vaccines in breast cancer treatment.
- To discuss the potential of immunotherapy for overcoming drug resistance.
- To highlight the role of immunologic memory in durable treatment and prevention.
Main Methods:
- Review of current understanding of tumor-specific antigens and immune response.
- Analysis of mechanisms underlying immunotherapy distinct from chemotherapy and hormone therapy.
- Examination of clinical trial data and translational challenges.
Main Results:
- Cancer vaccines demonstrate specificity and minimal toxicity.
- Immunotherapy can circumvent intrinsic drug resistance.
- Immunologic memory offers potential for long-term therapeutic effects and relapse reactivation.
Conclusions:
- Breast cancer vaccines represent a promising therapeutic modality.
- Further development can lead to immunotherapy for breast cancer treatment and prevention.
- Translational research is key to optimizing vaccine design and clinical application.